[Hypothyroidism and aging: the search for protective factors]. [PDF]
Probl Endokrinol (Mosk), 2023 Ilyushchenko AK +2 more
europepmc +1 more source
[Dynamics the parameters of mineral metabolism in hospitalized patients with COVID-19, the impact of etiotropic and pathogenetic therapy]. [PDF]
Probl Endokrinol (Mosk), 2023 Maganeva IS +8 more
europepmc +1 more source
[The causes of obesity relapse after weight loss]. [PDF]
Probl Endokrinol (Mosk), 2023 Guseinova RM +5 more
europepmc +1 more source
[Molecular and cellular mechanisms of ageing: modern knowledge (literature review)]. [PDF]
Probl Endokrinol (Mosk), 2023 Mikheev RK +6 more
europepmc +1 more source
[Myokines and adipomyokines: inflammatory mediators or unique molecules of targeted therapy for obesity?] [PDF]
Probl Endokrinol (Mosk), 2021 Vasyukova OV +3 more
europepmc +1 more source
[Short stature due to intrauterine growth retardation. Clinical and hormonal-metabolic features, possibilities of growth-stimulating therapy]. [PDF]
Probl Endokrinol (Mosk), 2022 Nagaeva EV.
europepmc +1 more source
[Metformin and malignant neoplasms: a possible mechanism of antitumor action and prospects for use in practice]. [PDF]
Probl Endokrinol (Mosk), 2022 Kuznetsov KO +10 more
europepmc +1 more source
[Molecular tumor board and theranostics]. [PDF]
Probl Endokrinol (Mosk), 2023 Rumyantsev PO.
europepmc +1 more source
[Synergistic effects of GABA and hypoglycemic drugs]. [PDF]
Probl Endokrinol (Mosk), 2023 Tyurenkov IN +2 more
europepmc +1 more source
[Myokines in obese adolescents with aerobic exercise]. [PDF]
Probl Endokrinol (Mosk), 2022 Kasyanova YV +4 more
europepmc +1 more source